Our Company was incorporated in the year 1996 for manufacture of Bulk
Pharma Ingredients and Intermediates for drug molecules and was
Mr. K. Hari Babu. Mr. N.S. Walimbe joined as copromoter in the year
Our Company was not having its own manufacturing facilities initially
premises and production facilities of Dr. Curie’s Labs Limited for a
period of two
years till 1998 under leave and license agreement, which terminated
1998. At this facility our Company manufactured 2,4 Dichloro 5 Fluoro
(DCFA) a drug intermediate for manufacture of Quinolones, which we
Dr. Reddy’s Laboratories Limited and Aurobindo Pharma Limited.
In July 14, 1998 an agreement for sale was entered into by our
Company with Andhra
Pradesh Industrial Development Corporation (APIDC) and Andhra Pradesh
Financial Corporation (APSFC) to purchase land, buildings and plant &
M/s Jay Organics Limited situated at Survey No. 17, Chilakamarri
Mahboobnagar District, Andhra Pradesh under Section 29 of the SFC
Act, 1952. M/s Jay
Organics Limited had defaulted in payment of loans to its lenders /
these Corporations and
in exercise of power under Section 29 of the SFC Act, 1952, the
lenders advertised the
sale of this unit and our Company offered to purchase this land,
building and plant &
machineries for a total consideration of Rs. 40.40 lakhs. On
acquisition of these facilities
we started our own manufacturing facilities.
Further with a view to add more products in our product profile we
entered into contracts
in 2004 with Nitya Laboratories Limited for conversion jobs for
manufacture of Sodium
Methoxide or Sodium Methylate Solution & Powder and CIS (+) Hydroxy
Methoxide and CIS Lactum contributed 9.73% and 24.27% respectively
during nine months
period ended December 31, 2007 in our total sales. For details of
contracts, please refer
to paragraph Other Agreements appearing on page number 95 of this Red
We are engaged in manufacture of Basic & Advanced Intermediates and
and are presently having manufacturing facilities for key
2,4-Dichloro-5-Fluoro Acetophenone (DCFA) (an intermediate for
antibiotics like ciprofloxacin); Chlorohexanone (key intermediate in
the manufacture of
cardio vascular medicine) and Methyl-4 (4-Chloro 1 oxo butane) a, a
Di-Methyl Acetate (an
intermediate in the manufacture of Fexofenadine an anti allergic
drug). DCFA have
contributed 28.81% of our total sales during the nine months period
ended December 31,
2007 whereas Methyl-4 (4-Chloro 1 oxo butane) a, a Di-Methyl Acetate
and Chlorohexanone contributed 8.95% of the total sales.
Our Company has a team of 25 chemists who are engaged in research and
Our in-house R&D team has manpower to handle complex molecular
synthesis and operations.
Our Company has presence in custom synthesis and contract research
process development and scaling up technologies in pilot plants. Our
in-house R&D facilities
are recognized by Government of India, Department of Scientific &
Industrial Research (DSIR),
which is at present valid till March 31, 2010. With continuous focus
on research & development,
our in-house R&D team has been able to develop process for some of
APIs / intermediates viz.
Diltiazem, Pentoxyfiline, Ciprofloxacin, Fexofenadine, Iopamidol and
Our Company has also been granted ISO 9001:2000 Certificate of
Assessment by AQA
International LLC with a scope of design development, manufacture and
supply of organic and
inorganic intermediates which is valid till December 30, 2008.
Our Company had started export of their products in the year 2002 to
Israel followed by exports to
other countries like Italy, Japan, France, USA and Singapore.
Currently, our exports comprise of
19.97% of our total turnover.
History and major events
1996 -97 * Incorporation of Anu’s Laboratories Limited for
manufacturing of Bulk Drug
* Started manufacturing in facility taken on
leave and License basis.
* First Product manufactured -2,4 Dichloro 5
Fluoro Acetophenone (DCFA)
1998-99 * Purchased land, building, Plant & Machinery of a
sick Unit through APSFC and
APIDC in a public bidding process
2001-02 * Introduced another major drug intermediate viz.
* Granted subsidy of Rs. 7.90 lakhs from Andhra
Pradesh Pollution Control Board
as incentive for implementing projects for
recovery of by-products and for
showing our commitment towards Cleaner
2002 -03 * Certified ISO 9001-2000 from AQA International to
manufacture and supply of organic and
2004-05 * Introduced another drug intermediate
Methyl-4(4-Chloro 1-Oxo butyl) a, a Di
Methyl Phenyl Acetate
2006-07 * Best Practices Award for Market penetration
leadership from Frost and Sullivan
for the year 2005.
-Anus Laboratories Ltd has recommended a Final Dividend of 15%.
-Anu's Laboratories has given the Bonus in the Ratio of 1:1
-Company has splits its Face value of Shares from Rs 10 to Re 1
Anu's Laboratories Ltd has informed BSE that the Company has acquired
Stilbene Chemicals Ltd.